Arthur Smalley

Evaxion Biotech is a Copenhagen based biotechnology company focused on the discovery and development of vaccines against cancer and infectious diseases.Founded in 2008 by Andreas Holm MattssonAndreas Holm Mattsson (CSO) and Niels Moeller (Former CEO, now COO). Evaxion is developing antigens and neo-epitopes for vaccines and antibodies using Artificial Intelligence, with the aim of solving some of the world’s most significant challenges to human health.

Evaxion Biotech is a Copenhagen based biotechnology company focused on the discovery and development of vaccines against cancer and infectious diseases.Founded in 2008 by Andreas Holm Mattsson (CSO) and Niels MoellerNiels Moeller (Former CEO, now COO). Evaxion is developing antigens and neo-epitopes for vaccines and antibodies using Artificial Intelligence, with the aim of solving some of the world’s most significant challenges to human health.

On April 5th, 2019, Evaxion announced the dosing of the first patient with EVX-01, Evaxion’s personalized cancer immunotherapy. EVX-01 is designed to engage the immune systemimmune system to mount a targeted response against neoepitope-expressing solid tumors. Evaxion believes that its state-of-the-art neoepitope detection technology PIONEER in combination with the improved cytokine activation profile observed in preclinical studies of EVX-01 could offer a potential efficacy advantage with reduced toxicities compared to other neoepitope cancer immunotherapies.

Evaxion Biotech is a Copenhagen based biotechnology company focused on the discovery and development of vaccines against cancer and infectious diseases.Founded in 2008 by Andreas Holm Mattsson (CSO) and Niels Moeller (Former CEO, now COO). Evaxion is developing antigens and neo-epitopes for vaccines and antibodies using Artificial IntelligenceArtificial Intelligence, with the aim of solving some of the world’s most significant challenges to human health.

This round of financing provides the company with the necessary funds to continue to advance the clinical work of the company’s EVX-01 personalized cancer immunotherapy in unresectable metastatic melanoma, non-small cell lung cancerlung cancer (NSCLC) & bladder cancer, as well as prepare EVX-02, a Phase 1b/2, study of personalized adjuvant immunotherapy in melanoma subjects, who are at high risk for recurrence.

On April 5th, 2019, Evaxion announced the dosing of the first patient with EVX-01, Evaxion’s personalized cancer immunotherapycancer immunotherapy. EVX-01 is designed to engage the immune system to mount a targeted response against neoepitope-expressing solid tumors. Evaxion believes that its state-of-the-art neoepitope detection technology PIONEER in combination with the improved cytokine activation profile observed in preclinical studies of EVX-01 could offer a potential efficacy advantage with reduced toxicities compared to other neoepitope cancer immunotherapies.

This round of financing provides the company with the necessary funds to continue to advance the clinical work of the company’s EVX-01 personalized cancer immunotherapy in unresectable metastatic melanoma, non-small cell lung cancer (NSCLC) & bladder cancerbladder cancer, as well as prepare EVX-02, a Phase 1b/2, study of personalized adjuvant immunotherapy in melanoma subjects, who are at high risk for recurrence.

• Codenvy - part of Red HatRed Hat, incorporates a facilitated solution at codenvy.io, and the undertaking open-source approach of Red Hat. The browser editor allows coders to edit, build, run, and debug projects. It supports languages like HTML, CSS, JavaScript, Java, Groovy, Ruby, PHP, and Python.

• SourceLair - allows users to develop various web applications in Django, Node.js, HTML5HTML5, and PHP, while it combines with Git, GitHub, and Heroku.

• Repl.it - Python Web IDE. Supports text output and allows users to create plots and charts using MatplotlibMatplotlib (and other libraries).

• Source code editor: A text editortext editor that can assist in writing software code. Often with features such as syntax highlighting, language-specific auto-completion, and real-time checking for bugs as code is being written.

• Codenvy - part of Red Hat, incorporates a facilitated solution at codenvy.io, and the undertaking open-source approach of Red Hat. The browser editor allows coders to edit, build, run, and debug projects. It supports languages like HTML, CSS, JavaScript, Java, GroovyGroovy, Ruby, PHP, and Python.

• Arduino Web Editor - ArduinoArduino’s own Create Web editor. Alongside the code editor, the library manager and serial monitor are also available in the browser.

• CodeAnywhere - allows coders to edit files from services like FTP, GitHub, Dropbox, and others as well as the ability to collaborate and share through Codeanywhere on any device. Supports Javascript, PHP, HTMLHTML, and 72 other programming languages.

• Gitpod - IDE for GitHub or GitLabGitLab projects.

• Cloud9 - Amazon’s AWS IDE, Cloud9 has basic tools for well-known programming languages like JavaScriptJavaScript, Python, PHP, and more.

• SourceLair - allows users to develop various web applicationsweb applications in Django, Node.js, HTML5, and PHP, while it combines with Git, GitHub, and Heroku.

• Koding - Koding’s configuration manager can handle HerokuHeroku with MongoDB & Node.js, or AWS with Ruby and MySQL.

• CodeAnywhere - allows coders to edit files from services like FTP, GitHub, DropboxDropbox, and others as well as the ability to collaborate and share through Codeanywhere on any device. Supports Javascript, PHP, HTML, and 72 other programming languages.

• Visual Studio Online - MicrosoftMicrosoft's web-based version of its Visual Studio IDE.